Inventor
EMTAGE PETER
US17 patents
⚠️ This page may combine multiple inventors who share the name “EMTAGE PETER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CELL DESIGN LABS INC
6 patentsUS11325957B2May 10, 2022
Methods and compositions for reducing the immunogenicity of chimeric notch receptors
CELL DESIGN LABS INC3 citations63
US12570958B2Mar 10, 2026
Single- and multi-chain chimeric antigen receptors
CELL DESIGN LABS INC0 citations56
US11993660B2May 28, 2024
Chimeric polypeptides and methods of altering the membrane localization of the same
CELL DESIGN LABS INC0 citations54
US11111310B2Sep 7, 2021
Chimeric polypeptides and methods of altering the membrane localization of the same
CELL DESIGN LABS INC0 citations54
US12297243B2May 13, 2025
Methods and compositions for reducing the immunogenicity of chimeric notch receptors
CELL DESIGN LABS INC0 citations50
US12065498B2Aug 20, 2024
Methods of making bispecific anti-CD307E and anti-BCMA chimeric antigen receptors and uses of the same
CELL DESIGN LABS INC0 citations47
PRECIGEN INC
5 patentsUS11118168B2Sep 14, 2021
Expression of novel cell tags
PRECIGEN INC4 citations80
US12060585B2Aug 13, 2024
Expression of novel cell tags
PRECIGEN INC1 citations69
US12180517B2Dec 31, 2024
Expression of novel cell tags
PRECIGEN INC0 citations59
US12559536B2Feb 24, 2026
CD33 specific chimeric antigen receptors
PRECIGEN INC0 citations57
US11787848B2Oct 17, 2023
CD33 specific chimeric antigen receptors
PRECIGEN INC1 citations57
KITE PHARMA INC
4 patentsUS11708401B2Jul 25, 2023
Chimeric transmembrane proteins and uses thereof
KITE PHARMA INC2 citations65
US12109235B2Oct 8, 2024
TGF-beta receptors and methods of use
KITE PHARMA INC1 citations56
US12280119B2Apr 22, 2025
Chimeric transmembrane proteins and uses thereof
KITE PHARMA INC0 citations55
US12551530B2Feb 17, 2026
Immune cell function
KITE PHARMA INC0 citations52